Skip to main content
. 2023 May 20;12(10):1433. doi: 10.3390/cells12101433

Figure 7.

Figure 7

Expression of IDO2 in Ki67-low and Ki67-high breast cancers. The Breast Cancer Gene−Expression Miner v4.9 tool was used to assess IDO2 mRNA expression (1568638_a_at, Affymetrix expression data) in breast tumors that were Ki67-low vs. Ki67-high, as assessed via Ki67 immunohistochemistry. Statistical analysis is an embedded feature of this tool with the Welch t-test’s p-value included in the plot inset. Sample numbers are indicated in parentheses beneath the plot.